Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 40,000 shares at $72.04 ($2.9M) on 2019-01-07, disclosed to the SEC on 2019-01-09.
Open-market sale of $2.9M RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.04 | 20,000 | $1.4M | 50.0% |
| 2 | $72.04 | 20,000 | $1.4M | 50.0% |
| Total | $72.04 avg | 40,000 | $2.9M | 100% |
| Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-08-16 | $420K | — | Filing → |
| RETA | SELL | 2019-07-17 | $574K | — | Filing → |